Micrologix raises $27.2 million

Micrologix Biotech (TSE:MBI; MGIXF), a developer of antimicrobial drugs, raised C$40 million (US$27.2 million) through the sale of 4 million special warrants at C$10 (US$6.80). The underwriters also r...